Bachelor's degree in Finance or Accounting required.
8-10+ years of relevant financial experience, preferably in Corporate Finance, FP&A, or Accounting.
Experience in the biotech or pharmaceutical industry, particularly in clinical trial finance, is strongly preferred.
Strong understanding of accounting and finance principles with excellent financial analysis skills.
Proven ability to influence across functions and engage with senior stakeholders effectively.
Ability to manage multiple projects and priorities under tight deadlines.
Highly proficient in Microsoft Excel and PowerPoint; familiarity with SAP and Adaptive Planning is a plus.
Responsibilities
Provide strategic finance support to Pipeline Delivery leaders, overseeing budget versus actual spend and reforecasting.
Collaborate with leadership to develop scalable operating models and vendor oversight processes.
Support clinical trial financial management, including expense accruals and forecasting, in partnership with key stakeholders.
Deliver timely and actionable financial analysis to inform R&D governance discussions.
Consolidate and report on R&D functions and programs as part of the broader R&D Finance team.
Act as a clinical finance subject matter expert, guiding team members and promoting best practices.
Prepare presentations for internal and external stakeholders, including executive audiences.
Benefits
Comprehensive medical, dental, and vision coverage.
Life and disability insurance.
Lifestyle reimbursement program and flexible spending accounts.
401(k) plan with a generous company match.
Paid time off, wellness days, and holidays.
Two company-wide recharge breaks.
Generous family resources and leave.
Full Job Description
Overview
The Associate Director, R&D Finance partners with business leaders across Alnylam as a member of the Financial Planning and Analysis team. Reporting to the Director, FP&A, this role will have a primary focus on strategic financial support for the Development organization.
This is a hybrid and is primarily based in Cambridge, MA.
Responsibilities
Provide strategic finance support to key Pipeline Delivery leaders (e.g., Clinical Operations, Data Management), including financial oversight of actual spend versus budget, reforecasting, long-range planning, and strategic decision support.
Partner with Pipeline Delivery leadership as the organization evolves to meet Alnylam 2030 goals, including developing scalable and sustainable operating models, key vendor oversight processes, and study budget and scope procedures.
Partner with multiple Clinical Operations therapeutic area leaders to provide financial support, including clinical trial expense accruals and forecasting, in close collaboration with accounting, sourcing, business operations, and other key stakeholders. Drive improvements to trial financial management processes as the pipeline grows.
Collaborate with functional, program, and matrixed finance partners to deliver timely, accurate, and actionable financial analysis that informs R&D governance discussions and decision-making.
Support broader R&D Finance team deliverables, including consolidation and reporting for R&D functions and programs.
Serve as a clinical finance subject matter expert within the R&D Finance team, sharing knowledge of clinical trial financial management, providing guidance to team members, and promoting best practices.
Prepare recurring and ad hoc presentations for a variety of internal and external stakeholders, including executive-level audiences.
Collaborate with key stakeholders to develop and improve existing processes and reporting, and implement changes where appropriate.
Work closely with colleagues across the broader Finance organization to maintain a continuous improvement mindset and promote strong communication and efficient processes.
Support special projects and ad hoc analyses as needed for the broader R&D Finance team.
Qualifications
Bachelor's degree required, preferably in Finance or Accounting.
8-10+ years of relevant financial experience (e.g., Corporate Finance, FP&A, Accounting), or an equivalent combination of education and experience.
Experience in the biotech or pharmaceutical industry and clinical trial finance experience strongly preferred.
Comprehensive understanding of accounting and finance principles, with strong financial analysis and data interpretation skills.
Proven ability to partner and influence across functions, share insights with senior stakeholders, and drive timely execution of project plans.
Ability to manage multiple assignments and competing priorities under tight deadlines.
Highly proficient in Microsoft Excel and PowerPoint; experience with SAP and Adaptive Planning is a plus.
#LI-MH1 #LI-Hybrid
The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills, and education. This role is eligible for an annual short-term incentive award (e.g., bonus or sales incentive) and an annual long-term incentive award (e.g., equity).
Alnylam's robust Total Rewards package is designed to support your overall health and well-being. We offer comprehensive benefits including medical, dental, and vision coverage, life and disability insurance, a lifestyle reimbursement program, flexible spending and health savings accounts and a 401(k)with a generous company match. Eligible employees enjoy paid time off, wellness days, holidays, and two company-wide recharge breaks. We also offer generous family resources and leave. Our commitment to your well-being reflects our belief that caring for our people fuels the impact we create together.
Learn more about these and additional benefits offered by Alnylam by visiting the Benefits section of the Careers website: https://www.alnylam.com/careers
U.S. Pay Range
$162,400-$219,600 USD
About Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biotechnology company that focuses on RNA interference (RNAi) therapeutics. The company's products are designed to silence specific genes that cause diseases. Alnylam's pipeline includes products for the treatment of genetic, cardio-metabolic, and hepatic infectious diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.